UsAgainstAlzheimer's Letter to FDA on Pimavanserin (5.3.21)

Paid Family and Medical Leave Joint Letter (NAC, UsAgainstAlzheimer's, The Arc)

UsAgainstAlzheimer’s Survey #8 on COVID-19 and Alzheimer’s Community February/March 2021 Summary of Findings

WA2 Leadership Council Overview

Summary of Findings: UsAgainstAlzheimer’s Survey on Attitudes Toward Use of a Disease-Modifying Alzheimer’s Therapy

UsAgainstAlzheimer's Letter to FDA on Aducanumab (1.19.21)